|
Subsequent Events (Narrative) (Details) (Subsequent event, USD $)
In Millions, unless otherwise specified |
1 Months Ended |
|---|---|
|
Apr. 30, 2015
|
|
| Quanticel Pharmaceuticals | |
| Subsequent Event [Line Items] | |
| Payments for acquisition of business | $ 100 |
| Development milestone | Quanticel Pharmaceuticals | |
| Subsequent Event [Line Items] | |
| Potential contingent consideration | 385 |
| Strategic collaboration agreement | MedImmune | MEDI4736 | |
| Subsequent Event [Line Items] | |
| Milestone payment, payable | $ 450 |
| Percentage of responsible costs | 7500.00% |
| Royalty rate, percentage of worldwide sales | 7000.00% |
| Royalty rate. decrease | 5000.00% |
| Royalty rate percentage, decrease period | 4 years |